NYSE: ATR
Aptargroup Inc Stock

$158.33-1.40 (-0.88%)
Updated Jul 10, 2025
ATR Price
$158.33
Fair Value Price
N/A
Market Cap
$10.46B
52 Week Low
$130.85
52 Week High
$178.03
P/E
28.37x
P/B
4.12x
P/S
2.77x
PEG
4.08x
Dividend Yield
0.85%
Revenue
$3.55B
Earnings
$370.24M
Gross Margin
38.2%
Operating Margin
14.54%
Profit Margin
10.4%
Debt to Equity
0.78
Operating Cash Flow
$634M
Beta
0.71
Next Earnings
Jul 23, 2025
Ex-Dividend
N/A
Next Dividend
N/A

ATR Overview

AptarGroup, Inc. manufactures consumer dispensing packaging and drug delivery devices. Its packaging solutions are offered in the beauty, personal care, and home care sectors. Its drug delivery devices include nasal pumps and metered dose inhaler valves. Other offerings include dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves. Aptar was incorporated in 1992 and is headquartered in Crystal Lake, IL.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ATR's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical

Industry Rating
C
ATR
Ranked
#26 of 45

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$6.19A
$10.73B
$95.17B
View Top Medical Stocks

Be the first to know about important ATR news, forecast changes, insider trades & much more!

ATR News

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ATR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATR ($158.33) is trading above its intrinsic value of $44.68, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ATR is good value based on its earnings relative to its share price (28.37x), compared to the US market average (30.8x)
P/E vs Market Valuation
ATR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ATR due diligence checks available for Premium users.

Valuation

ATR price to earnings (PE)

For valuing profitable companies with steady earnings

Company
28.37x
Industry
39.59x
Market
30.8x
ATR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ATR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

ATR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.12x
Industry
3.71x
ATR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATR price to earnings growth (PEG)

For valuing profitable companies with growth potential

ATR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

ATR's financial health

Profit margin

Revenue
$887.3M
Net Income
$78.8M
Profit Margin
8.9%
ATR's Earnings (EBIT) of $516.86M... subscribe to Premium to read more.
Interest Coverage Financials
ATR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.5B
Liabilities
$2.0B
Debt to equity
0.78
ATR's short-term assets ($1.51B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATR's short-term assets ($1.51B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ATR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$82.7M
Investing
-$56.6M
Financing
-$134.8M
ATR's operating cash flow ($633.82M)... subscribe to Premium to read more.
Debt Coverage Financials

ATR vs Medical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ATRC$10.46B-0.88%28.37x4.12x
STVNC$7.86B+2.69%50.17x4.94x
RGENC$7.53B+3.22%-319.05x3.79x
HOLXC$14.90B+1.52%27.97x3.23x
BAXB$15.24B-0.37%-27.00x2.15x

Aptargroup Stock FAQ

What is Aptargroup's quote symbol?

(NYSE: ATR) Aptargroup trades on the NYSE under the ticker symbol ATR. Aptargroup stock quotes can also be displayed as NYSE: ATR.

If you're new to stock investing, here's how to buy Aptargroup stock.

What is the 52 week high and low for Aptargroup (NYSE: ATR)?

(NYSE: ATR) Aptargroup's 52-week high was $178.03, and its 52-week low was $130.85. It is currently -11.07% from its 52-week high and 21% from its 52-week low.

How much is Aptargroup stock worth today?

(NYSE: ATR) Aptargroup currently has 66,040,697 outstanding shares. With Aptargroup stock trading at $158.33 per share, the total value of Aptargroup stock (market capitalization) is $10.46B.

Aptargroup stock was originally listed at a price of $13.88 in Dec 31, 1997. If you had invested in Aptargroup stock at $13.88, your return over the last 27 years would have been 1,041.12%, for an annualized return of 9.44% (not including any dividends or dividend reinvestments).

How much is Aptargroup's stock price per share?

(NYSE: ATR) Aptargroup stock price per share is $158.33 today (as of Jul 10, 2025).

What is Aptargroup's Market Cap?

(NYSE: ATR) Aptargroup's market cap is $10.46B, as of Jul 11, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aptargroup's market cap is calculated by multiplying ATR's current stock price of $158.33 by ATR's total outstanding shares of 66,040,697.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.